{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:26:40Z","timestamp":1759667200629},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Katrin Dobschal"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ticks and Tick-borne Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ttbdis.2017.12.008","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T14:09:58Z","timestamp":1513001398000},"page":"415-417","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Matthias","family":"Karrasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Fingerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Boden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Darr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Straube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Nenadic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ttbdis.2017.12.008_bib0005","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","author":"Baumeister","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.ttbdis.2017.12.008_bib0010","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-130446","article-title":"Lyme neuroborreliosis and dementia","volume":"41","author":"Blanc","year":"2014","journal-title":"J. Alzheimer's Dis.: JAD"},{"issue":"5","key":"10.1016\/j.ttbdis.2017.12.008_bib0015","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"van Burgel","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.ttbdis.2017.12.008_bib0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00415-011-6221-8","article-title":"Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis","volume":"259","author":"Djukic","year":"2012","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.ttbdis.2017.12.008_bib0025","first-page":"446","article-title":"Lyme neuroborreliosis-epidemiology, diagnosis and management. Nature reviews","volume":"11","author":"Koedel","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ttbdis.2017.12.008_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00284-005-0454-7","article-title":"Lyme disease associated with Alzheimer's disease","volume":"52","author":"Meer-Scherrer","year":"2006","journal-title":"Curr. Microbiol."},{"issue":"4","key":"10.1016\/j.ttbdis.2017.12.008_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/JAD-2008-13404","article-title":"Chronic inflammation and amyloidogenesis in Alzheimer's disease \u2212 role of Spirochetes","volume":"13","author":"Miklossy","year":"2008","journal-title":"J. Alzheimer's Dis.: JAD"},{"issue":"5","key":"10.1016\/j.ttbdis.2017.12.008_bib0040","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ajpath.2015.01.024","article-title":"Inflammation in the pathogenesis of lyme neuroborreliosis","volume":"185","author":"Ramesh","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"April (4)","key":"10.1016\/j.ttbdis.2017.12.008_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","article-title":"CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine","volume":"85","author":"Rupprecht","year":"2014","journal-title":"Nervenarzt"},{"issue":"January (1)","key":"10.1016\/j.ttbdis.2017.12.008_bib0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-016-2112-z","article-title":"Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization","volume":"17","author":"Schwenkenbecher","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.ttbdis.2017.12.008_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","article-title":"Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to theC6-peptide in Lyme neuroborreliosis","volume":"62","author":"Tjernberg","year":"2011","journal-title":"J. Infect."}],"container-title":["Ticks and Tick-borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X17305678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X17305678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T15:34:55Z","timestamp":1553096095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877959X17305678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1877959X17305678"],"URL":"https:\/\/doi.org\/10.1016\/j.ttbdis.2017.12.008","relation":{},"ISSN":["1877-959X"],"issn-type":[{"value":"1877-959X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis","name":"articletitle","label":"Article Title"},{"value":"Ticks and Tick-borne Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ttbdis.2017.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}